Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Payables (2020 - 2025)

Historic Payables for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $71.2 million.

  • Cellebrite DI's Payables rose 1249.64% to $71.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $71.2 million, marking a year-over-year increase of 1249.64%. This contributed to the annual value of $71.2 million for FY2025, which is 1249.64% up from last year.
  • Cellebrite DI's Payables amounted to $71.2 million in Q4 2025, which was up 1249.64% from $62.5 million recorded in Q3 2025.
  • Cellebrite DI's Payables' 5-year high stood at $71.2 million during Q4 2025, with a 5-year trough of $35.6 million in Q2 2023.
  • For the 5-year period, Cellebrite DI's Payables averaged around $50.3 million, with its median value being $48.4 million (2022).
  • Its Payables has fluctuated over the past 5 years, first plummeted by 2494.05% in 2023, then surged by 6083.91% in 2025.
  • Quarter analysis of 5 years shows Cellebrite DI's Payables stood at $54.0 million in 2021, then fell by 15.9% to $45.5 million in 2022, then decreased by 1.34% to $44.8 million in 2023, then surged by 41.22% to $63.3 million in 2024, then increased by 12.5% to $71.2 million in 2025.
  • Its Payables stands at $71.2 million for Q4 2025, versus $62.5 million for Q3 2025 and $68.0 million for Q2 2025.